Resolution of the Committee of Ministers on the Doping of Athletes / Committee of Ministers of the Council of Europe. - Strasbourg : Council of Europe (CoE), 1967. - (Council of Europe Resolution (67) 12; 29 June 1967)

The Committee of Ministers of the Council of Europe, Recommends on 29 June 1967 the Governments of member States:

1.) to persuade the sports associations and federations which organise competitions in their territory to take action if necessary with their international federations and, if they have not already done so, to issue regulations:
- (a) condemning the use, or procedures to facilitate the use, in preparation for or during a sports competition, of the substances or processes employed for doping as defined in the Preamble to this Recommendation;
- (b) penalising offenders by prohibiting them, temporarily or permanently, from taking part in, organising or acting in an official capacity at any sports competition;
- (c) applying the regulations to any person who, in another member State, has been penalised in accordance with the provisions of paragraph (b) above;
2.) to take the appropriate measures at their disposal to achieve the objectives set forth in paragraph 1 above, if the regulations referred to in that paragraph have not, within three years from the date of this Recommendation, been issued or effectively applied.

The Committee of Ministers of the Council of Europe Invites the Governments of member States to keep it informed of action taken by them to implement this Recommendation.

Doping of athletes / O.D. Ratnoff, A.A. Miles. - (British Medical Journal (1964) 2 (29 August); p. 525)

• PMID: 14173180
• PMCID: PMC1816178
• DOI: 10.1136/bmj.2.5408.525

With the Tokyo Olympics in mind, the British Association of Sport and Medicine has issued a policy statement on the doping of athletes and sportsmen, which, it states, is being sent to " all the governing bodies of sport." A major difficulty in drafting such a statement is the definition of what, in this context, constitutes "doping."

Cholestasis produced by the administration of norethandrolone / Fenton Schaffner, Hans Popper, Eugene Chesrow. - (American Journal of Medicine 26 (1959) 2 (1 February); p. 249-254)

• PMID: 13617282
• DOI: 10.1016/0002-9343(59)90314-6

Norethandrolone was administered to 27 patients for three to five weeks. Liver biopsies were performed before and after administration of the drug. Histologic evidence of cholestasis was found in four patients. In each of these instances the serum glutamic oxalacetic-transaminase activity increased above 150 units from normal levels. In one patient severe jaundice developed which lasted ten weeks. The remaining patients tolerated the drug well and gained weight. In a control group of 28 patients receiving a tranquilizing drug and similarly studied no instances of cholestasis were found.
Inflammatory reaction in the portal tracts and around proliferated ductules (cholangiolitis) was not associated with the cholestasis although it was present in some patients before and after administration of norethandrolone.